2023-2029 Global COVID-19 Home Testing Products Industry Research & Trends Analysis Report

According to YH Research, the global market for COVID-19 Home Testing Products should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China COVID-19 Home Testing Products market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States COVID-19 Home Testing Products market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Latex Method segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of COVID-19 Home Testing Products include ACON Biotech (Hangzhou) Co., Ltd., Xiamen AmonMed Biotechnology Co., Ltd., Bioda Diagnostics (Wuhan) Co., Ltd., Xiamen Biotime BiotechnologyCo.,Ltd., Biohit Healthcare (Hefei) Co., Ltd., Shanghai Biogerm Medical Technology Co.，ltd,, Bioscience( Tianjin ) Diagnostic Technology Co., Ltd,, Zhejiang Orient Gene Biotech Co.,Ltd. and Shanghai Fosun Pharmaceutical(Group)Co.,Ltd., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
COVID-19 Home Testing Products are easy-to-use, accurate and reliable rapid antigen test that provides results in a short time.
This report aims to provide a comprehensive study of the global market for COVID-19 Home Testing Products. Report Highlights:
(1) Global COVID-19 Home Testing Products market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global COVID-19 Home Testing Products market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China COVID-19 Home Testing Products market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global COVID-19 Home Testing Products segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global COVID-19 Home Testing Products segment by type and by application and regional segment by type and by application.
(6) Global major production regions of COVID-19 Home Testing Products, capacity, production and trends.
(7) COVID-19 Home Testing Products industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Latex Method
Colloidal Gold Method
Market segment by application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
ACON Biotech (Hangzhou) Co., Ltd.
Xiamen AmonMed Biotechnology Co., Ltd.
Bioda Diagnostics (Wuhan) Co., Ltd.
Xiamen Biotime BiotechnologyCo.,Ltd.
Biohit Healthcare (Hefei) Co., Ltd.
Shanghai Biogerm Medical Technology Co.，ltd,
Bioscience( Tianjin ) Diagnostic Technology Co., Ltd,
Zhejiang Orient Gene Biotech Co.,Ltd.
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Beijing Savant Biotechnology Co.,Ltd.
Getein Biotech, Inc.
Hebei Gensure Biotech Inc
Chengdu Kanghua Biological Products Co.,Ltd.
SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD.
Shenzhen SEICHI Technologies Co., Ltd.
Lepu Medical Technology(Beijing)Co.,Ltd.
Chongqing M&d Biotechnology Co. Ltd,